Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 8Cholangiocarcinoma 2Resectable Pancreatic Carcinoma 1Peritoneal Neoplasms 1Pancreatitis, Chronic 1Pancreatitis 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Carcinoma, Acinar Cell 1

Interventions

Gemcitabine 112Cisplatin 76Oxaliplatin 44pembrolizumab 34Fluorouracil 32Capecitabine 30durvalumab 27Leucovorin 26lenvatinib 23Magnetic Resonance Spectroscopy 15Irinotecan 14Nivolumab 12Biopsy 12Albumin-Bound Paclitaxel 12tislelizumab 11Specimen Handling 11Radiofrequency Ablation 11Drug Therapy 11pemigatinib 10apatinib 10Taxes 10Floxuridine 10130-nm albumin-bound paclitaxel 10Radiotherapy 9Bevacizumab 9Platinum 8Folfox protocol 8Carboplatin 81,2-diaminocyclohexaneplatinum II citrate 8tremelimumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Cholangiocarcinoma × Pancreatectomy × Clear all
NCT02757859 2026-05-29

WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer

Thomas Jefferson University

Phase NA Active not recruiting
845 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Carcinoma, Acinar Cell, Cholangiocarcinoma

NCT03801915 2023-03-21

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡